By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


Company News
Arno Therapeutics Reports Third Quarter 2015 Financial Results And Business Update 11/17/2015 8:13:32 AM
Arno Therapeutics Data Demonstrate AR-12 As Novel Antifungal Drug Against Common Finger And Toenail Fungus, Onychomycosis 10/29/2015 7:36:47 AM
Arno Therapeutics Demonstrates AR-12 Has Potent Antiviral Activity Against Drug-Resistant HIV Strains 10/22/2015 7:40:57 AM
Arno Therapeutics To Present Late-Breaking Abstract On AR-12 As Novel Therapeutic Candidate Against HIV Multidrug Resistant Strains At 15th European AIDS Conference 9/25/2015 8:18:40 AM
Arno Therapeutics' AR-13 Data Show Promise As Potential New Therapeutic Option For Cystic Fibrosis Patients With Serious Bacterial Infections 9/24/2015 8:50:08 AM
Arno Therapeutics To Present Data On Trans-Fungal Delivery Of AR-12 At 2015 American Association Of Pharmaceutical Scientists (AAPS) Annual Exposition 9/21/2015 10:39:00 AM
Arno Therapeutics Data Demonstrates Novel Antimicrobial Activity Of AR-12, Identified It As Lead Compound Of New Class Of Drugs 9/21/2015 7:59:35 AM
Arno Therapeutics Release: AR-12 Abstracts Accepted For Podium Presentation And Three Posters At ICAAC/ICC Annual Meeting 2015 9/14/2015 11:36:13 AM
Arno Therapeutics To Present At 17th Annual Rodman & Renshaw Conference 9/1/2015 12:34:25 PM
Arno Therapeutics Receives Authorization to Proceed With Modified Phase I/II Trial Evaluating Onapristone In Prostate Cancer 8/18/2015 7:53:41 AM